英文版
Linzess (linaclotide)
药品使用说明书
用于便秘肠易激综合征 / 慢性特发性便秘
合肥到厦门
HAOEYOU ( 好医友)
1 INDICATIONS AND USAGE蒙氏语录
1.1 Irritable Bowel Syndrome with Constipation (IBS-C)1.2 Chronic Idiopathic Constipation (CIC)2 DOSAGE AND ADMINISTRATION
2.1 Irritable Bowel Syndrome with Constipation (IBS-C)2.2 Chronic Idiopathic Constipation (CIC)2.3 Important Administration Instructions 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS
5 WARNINGS AND PRECAUTIONS 5.1 Pediatric Risk 5.2 Diarrhea
煎海蛎6 ADVERSE REACTIONS 6.1 Clinical Trials Experience
7 DRUG INTERACTIONS
8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy
8.3 Nursing Mothers 8.4 Pediatric U 8.5 Geriatric U
8.6 Hepatic or Renal Impairment 10 OVERDOSAGE 11 DESCRIPTION
奥特曼的故事12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.2 Pharmacodynamics 12.3 Pharmacokinetics
13 NONCLINICAL TOXICOLOGY梨花头
13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility 13.2 Animal Toxicology and/or Pharmacology 14 CLINICAL STUDIES
14.1 Irritable Bowel Syndrome with Constipation (IBS-C)14.2 Chronic Idiopathic Constipation (CIC)
16 HOW SUPPLIED/STORAGE AND HANDLING 17 PATIENT COUNSELING INFORMATION
*FULL PRESCRIBING INFORMATION
1 INDICATIONS AND USAGE
Sections or subctions omitted from the full prescribing information are not listed.
校园手抄报图片WARNING: PEDIATRIC RISK
LINZESS is contraindicated in pediatric patients up to 6 years of age; in nonclinical studies,administr
ation of a single, clinically relevant adult oral do of linaclotide caud deaths due to dehydration in young juvenile mice. Avoid u of LINZESS in pediatric patients 6
海底两万里好句赏析through 17 years of age. The safety and efficacy of LINZESS has not been established in pediatric patients under 18 years of age [e Contraindications (4), Warnings and Precautions (5.1), U in Specific Populations (8.4) and Nonclinical Toxicology (13.2)].
2019生肖
